Clinical Trial

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Name: A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus — clinical trial record (NCT07590193)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The main objective of this trial is to assess the safety and tolerability of AMG 127 as single dose and multiple doses in healthy participants and participants with type 2 diabetes mellitus (T2DM).

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-24

Trial Details

NCT Number	NCT07590193
Lead Sponsor	Amgen
Conditions	Diabetes Mellitus, Type 2
Enrollment	162 participants
Start Date	2026-06-11
Primary Completion	2027-10-02 (estimated)
Study Completion	2027-10-02 (estimated)
Updated on ClinicalTrials.gov	2026-08-03